Medpace Holdings (MEDP) Other Working Capital Changes (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Other Working Capital Changes came in at $21.2 million in Q2 2026, up 36.37% on a YoY basis from $15.6 million in Q2 2025, and up 501.27% quarter-over-quarter from -$5.3 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Other Working Capital Changes (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Other Working Capital Changes for 12 consecutive years, with $21.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Working Capital Changes rose 36.37% year-over-year to $21.2 million; the trailing twelve-month figure through Jun 2026 stood at $9.9 million (up 2001.69% YoY), and the FY2025 full-year result was $27.1 million, up 226.6% from the prior year.
- Other Working Capital Changes improved to $21.2 million in Q2 2026 per MEDP's latest filing, from -$5.3 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $109.8 million in Q2 2025 and bottomed at -$15.0 million in Q1 2023.
- Historically, Other Working Capital Changes has averaged $31.1 million across 5 years, with a median of $30.4 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes sank 1786.78% in 2023, then jumped 855.13% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$33.3 million in 2022, then jumped by 86.67% to -$4.4 million in 2023, then plunged by 34.91% to -$6.0 million in 2024, then surged by 855.13% to $45.2 million in 2025, then plunged by 53.04% to $21.2 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $21.2 million, -$5.3 million, and $45.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.16 Mn |
| Jun 30, 2026 | 40.16 Mn |
| Mar 31, 2026 | 10.17 Mn |
| Mar 31, 2026 | 10.17 Mn |
| Dec 31, 2025 | 20.06 Mn |
| Dec 31, 2025 | 20.06 Mn |
| Sep 30, 2025 | 25.55 Mn |
| Sep 30, 2025 | 25.55 Mn |
| Jun 30, 2025 | 109.79 Mn |
| Jun 30, 2025 | 109.79 Mn |
| Mar 31, 2025 | -11.59 Mn |
| Mar 31, 2025 | -11.59 Mn |
| Dec 31, 2024 | 39.65 Mn |
| Dec 31, 2024 | 39.65 Mn |
| Sep 30, 2024 | 32.52 Mn |
| Sep 30, 2024 | 32.52 Mn |
| Jun 30, 2024 | 21.72 Mn |
| Jun 30, 2024 | 21.72 Mn |
| Mar 31, 2024 | 56.84 Mn |
| Mar 31, 2024 | 56.84 Mn |